SEC freezes Nasdaq’s Bitcoin options approval as CME wages jurisdictional turf war

The SEC just hit pause on one of the most anticipated Bitcoin derivatives products of the year, and the reason has less to do with Bitcoin itself and more to do with a very old-fashioned regulatory turf war. Nasdaq PHLX’s proposed cash-settled Bitcoin index options, known as QBTC, have been frozen by the full SEC commission following a jurisdictional challenge from the CME Group. The suspension, effective around July 31, opens a public comment window running through August 24. In plain English: two of the biggest names in traditional finance are fighting over who gets to be the referee for Bitcoin derivatives. What happened and why it matters Here’s the backstory. The SEC granted Nasdaq conditional approval for the QBTC options back in May 2026 on an expedited basis. The product was designed to track the Nasdaq Bitcoin Index, which divides the CME CF Bitcoin Real Time Index by 100. That same benchmark underpins CME’s own Bitcoin futures and options contracts. Then CME filed a jurisdictional challenge on or around June 11. The core argument is straightforward: Bitcoin is a commodity, not a security. If that’s the case, cash-settled options based on a Bitcoin index should fall under ...